Royal Bank of Canada reaffirmed their sector perform rating on shares of DocuSign (NASDAQ:DOCU – Free Report) in a research ...
Chemed (NYSE:CHE – Free Report) had its price target hoisted by Royal Bank of Canada from $633.00 to $667.00 in a research report released on Friday,Benzinga reports. They currently have an outperform ...
UBS Group raised Progressive’s price target from $275 to $285, reflecting a modest 0.40% upside potential. Other firms, ...